Uncapped: Stories from the Grey Market

This episode breaks down what GMP and cGMP actually mean, and why broad cGMP claims on RUO peptide websites should be treated with scepticism.GMP and cGMP are strict quality systems overseen by regulators such as the FDA. They require traceability, documented processes, controlled environments, QA oversight, and inspection. If those controls are missing, the GMP claim falls apart.A major grey-market tactic is confusing API GMP with finished-product GMP. An API certificate may say something about the raw peptide powder, but it does not prove anything about the final vial: filling, lyophilisation, sterility, storage, or batch release.The contradiction becomes sharper when products are labelled Research Use Only while also being marketed as cGMP compliant. RUO products sit outside the drug regulatory framework, while cGMP implies regulated manufacturing controls.A legitimate US cGMP claim should be traceable. At minimum, buyers should be able to ask for the facility name, FEI number, registration status, inspection history, and the scope of what is actually GMP-compliant.Without that, “cGMP compliant” is not evidence. It’s marketing.

How “seized shipments” turn into second profits and why the same buyers may pay twiceScams are nothing new in the grey market.But this one works a little differently.In this episode, we break down what’s being described as the “Phoenix group buy scam” a pattern where a failed or allegedly failed group buy may not be the end of the story.Instead, it can become the starting point for something else.We walk through how these setups typically unfold:how trust is built inside the communityhow buyers are funnelled into group buyshow delays and shortages are normalisedand how the narrative is already in place before anything goes wrongUsing the Opaline Health & Science case as a real example, Part 1 focuses on the structure, not the outcome.Because the key question isn’t just what happened.It’s how the system was built to begin with.

This episode explores a side of the grey zone that isn’t talked about enough.Not the peptides. Not the vendors. Not the scams.But the people.Inside tight-knit communities, friendship often comes with conditions. You’re valuable while you’re useful. But when that changes, so does the relationship.From gossip, alt accounts, back stabbing and surveillance… to something more personal, the emotional whiplash of people who feel real, disappear, and then return like nothing happened.This episode is a reflection on hypocrisy, status, loyalty and the shifting terms of friendship in the grey zone

Scams, impersonators, vendor disputes, disappearing chats, and a collaboration offer I definitely wasn’t expecting.This episode is a real-time look at what one day in the grey zone actually looks like for me, narrated in my own voice.

What really happens when tirzepatide and vitamin B12 are mixed in the same vial?In this deep dive, we break down the science behind Eli Lilly’s recent warning and preprint, which identified a previously unknown tirzepatide–B12 molecular complex in compounded samples, in some cases making up a significant portion of the vial. The analysis also revealed major potency variation, with some products testing far below their labelled strength.But the real question isn’t just what was found, it’s what it actually means.We explore:how and why molecules interact differently in a shared vial vs the human bodywhat Lilly’s analytical data proves, and what it doesn’twhy formulation conditions (pH, concentration, solvent) can drive structural changeand how theoretical risks like aggregation and immunogenicity should be interpretedThis episode separates chemical possibility from clinical reality, and explains why understanding where interactions occur is key to understanding whether they matter at all.

What their data shows and what it still doesn't explain.What happens when a blockbuster drug meets a common vitamin?In this deep dive, we unpack Eli Lilly’s warning about tirzepatide mixed with vitamin B12, and the science behind the controversy.A newly released preprint shows that when the two are combined, they can form a previously unknown molecular complex, detected in real world samples. Some products were also found to be significantly under strength, raising broader concerns about quality in the secondary market.But while the chemistry is real, the key question remains unanswered:does any of this actually matter for patients?We break down:what Lilly’s data actually proveshow the molecules interact at a structural levelwhy lab findings don’t automatically translate to real-world riskand how this fits into the wider $100B GLP-1 market battleThis isn’t just a story about one drug or one impurity, it’s about the gap between analytical evidence and clinical reality, and what happens when patients are caught in the middle.

Why do some labs report 99%+ purity for NAD, while others refuse to give a purity number at all?This episode unpacks what is known as the NAD Testing Paradox.NAD is often analysed using methods designed for peptides, but chemically it behaves very differently. Because NAD naturally breaks down into related molecules like nicotinamide, ADP-ribose, AMP and ADP, purity numbers can sometimes reflect the analytical method used, rather than the actual chemical state of the molecule.Using real COA examples, this episode explores;why peptide style testing can be misleading for NADhow different labs can end up reporting very different numberscases where laboratories even disagreed on the identity of a samplewhat a properly selective NAD testing method actually looks likeThe goal isn’t to criticise labs, but to explain why NAD purity numbers can appear contradictory, and what those results may actually be measuring.

How Telehealth, US Manufacturing and 503A Ambitions are Rebuilding the Peptide MarketThe peptide market may be moving into a new phase.For years, much of the industry operated through Research Use Only (RUO) websites selling peptides in a legal grey zone. But that model is coming under pressure from payment processors, regulators, and changing mrket expectations.This episode explores what may be replacing it.Rather than a simple shift from RUO vendors to legitimate pharmacies, a more complex infrastructure appears to be emerging: telehealth platforms, physician sign-off models, compounding pharmacies, and even underground U.S. manufacturing operations trying to move toward 503A licensing over time.We break down how clinics created demand for alternative peptide supply, why telehealth has become such an attractive distribution layer, what legitimate sterile compounding actually involves, and why some operators may be using telehealth as a bridge toward a more defensible healthcare structure.The key point is that this is not a clean transition from grey market to regulated pharmacy.It is a hybrid phase in which:some operations are fully licensed pharmaciessome are Telehealth driven prescribing systemssome are clinic facing vendor networks wrapped in physician sign-offand some may be underground U.S. manufacturers trying to acquire the telehealth layer now and the 503A wrapper laterDemand for peptides hasn’t disappeared.What’s changing is the infrastructure through which that demand is served, and who manages to control the next version of the market.

For years the grey-market peptide ecosystem operated in a strange legal balance. Products were sold under “Research Use Only” labels while being widely discussed in wellness communities, clinics, and online forums. Regulators knew the contradiction existed, but the system continued to function.So what is actually destabilising the RUO model now?In this episode we look at a factor that rarely gets discussed: payment processors.Behind the scenes, vendors report increasing pressure from banks and card networks. High-risk merchant classifications, rolling reserves, frozen balances, and sudden account shutdowns are becoming common. Some companies now struggle not because they can’t produce peptides, but because they can’t reliably get paid for them.We explore how payment infrastructure is beginning to shape business behaviour across the peptide market. Vendors are experimenting with crypto checkout bridges, limiting sales volumes to avoid scrutiny, or moving toward telehealth and compounding pharmacy partnerships that qualify for healthcare merchant certifications like LegitScript.From this perspective, the shift happening in the peptide industry may not simply be RUO vendors rebranding as PUO or moving toward compounding pharmacies.It may be something more fundamental.The companies that control the rails of money may ultimately decide which peptide business models survive.

In this episode we unpack the shift from Research Use Only (RUO) peptides to the emerging Physician Use Only (PUO) label.At first glance, PUO might look like a move toward a more legitimate, physician-driven distribution model. But a closer look suggests something more complex.PUO is not an FDA regulatory category and does not automatically place peptides inside licensed pharmacy frameworks such as 503A or 503B compounding. Instead, it appears to function primarily as a liability repositioning strategy, allowing vendors to distance themselves from direct human use claims while shifting more responsibility toward physicians and clinics.We explore how the original RUO label emerged, why that model began to break down, and how some vendors are now rebranding products for “physician use” while still operating outside formal drug approval pathways.The episode also looks at real examples from companies marketing peptides to clinicians while still including research-use disclaimers , creating a hybrid system where the marketing suggests therapeutic use but the legal framework remains unchanged.The key takeaway: PUO may change the language around peptides, but it does not necessarily change the underlying regulatory structure.And while RUO vendors rebrand, a parallel system built around telehealth and compounding pharmacies may be emerging at the same time.

In this audio version episode of K-Hole Origins: My Road to Grey, I talk about my experience with a vendor known as Cora and how a seemingly normal transaction slowly turned into a lesson in how the grey market actually works.It started in March 2024. Cora approached me warmly, calling me “dear friend,” reassuring me about shipping and reship policies, and sending an Alibaba payment link for tirzepatide. The first order actually arrived, which gave me confidence to place a second, larger order for several peptides.But once testing results came back through PTDS, the picture changed. Multiple products, MOTS-C, DSIP and Epitalon, were under dosed. When I asked for a refund, the conversation shifted into what I now recognise as the classic grey-market script: reassurance, batch excuses, replacement offers instead of refunds, and endless procedural delays.The refund became a negotiation. The amount kept shrinking. I was asked to keep the agreement secret and even asked to delete posts discussing the issue. When the agreed refund still didn’t appear, the process was pushed into complicated Alibaba procedures that never actually resolved anything.In the end, the only thing that worked was a credit-card chargeback.What began with hearts, “dear friend,” and friendly messages ended with a defence letter claiming I was unreasonable and spreading rumours.

XCE goes dark, panic spreads, and the scramble to replace a dominant vendor begins. In this episode of K-Hole Origins, I share the surreal reality of early group buys, the post-XCE chaos, and the moment I realised the grey market was never just about peptides, it was about power, loyalty, and who fills the vacuum next. 

In Episode 2 of K-Hole Origins: My Road to Grey, my first peptide order from China finally arrives. What should have been a straightforward experiment quickly raises doubts and pulls me deeper into the strange dynamics of the grey-market peptide community

In this episode I share the personal story of how I entered the grey-market peptide world, from early experiences with GLP-1 medications to placing my first direct order from China, the beginning of the journey that eventually led to K-Hole.

This episode of Behind the Vial explores what happens just before peptides are freeze-dried. It looks at the stage where the peptide is still in liquid solution, covering sterile filtration, solution preparation, peristaltic pump setup, and manual vial filling under laminar airflow. Using real factory footage, the episode shows how the solution is filtered, transferred, and dispensed into vials before moving on to the lyophilisation stage.

GLP1Forum; Manipulated Labels, Word Filters & BansIn grey-market communities, information and reputation are everything.But what if the reputations people see forming online aren’t as organic as they appear?This piece explores how moderation tools, word filters, bans, and platform design can influence which narratives survive and which disappear.Sometimes rumours spread.Sometimes they’re built directly into the system.

This episode explains the lyophilisation process used in peptide manufacturing, showing how liquid formulations are freeze dried to improve stability. It covers the key stages of freezing, primary drying, secondary drying, and final stoppering, and explains how water is removed by sublimation under vacuum. Using real factory footage from Aaron’s Biochemapi facility, the episode walks through what happens inside the freeze dryer and shows how partially stoppered vials become sealed, freeze-dried products.

This is a summary of my interview with Alex, co-founder of Uzorak, a new peptide testing lab based in Zagreb, Croatia, planning to operate globally.Alex comes from a health-tech background, including a DNA analytics company , and says his own peptide research is what pushed him into building a testing lab. His core argument is simple: in an unregulated market, testing standards should be higher, not lower. He believes people are going to use these compounds regardless, so harm reduction starts with better information about what’s actually in the vial.Uzorak’s offering goes beyond the standard “HPLC-UV purity + mass confirmation” COA. Their “Advanced LCMS Peptide Analysis” is positioned as a bundled package: high resolution LC-MS, impurity identification and quantification, MS/MS sequence confirmation, and tandem MS fingerprinting to check for structural damage versus a reference. They also add a scoring model with published weights, purity, potency, and integrity, plus risk triggers, and they separate “alteration” signals like oxidation and deamidation from “hazard” categories like hydrolysis, cleavage, and synthesis residues.One of the big clarifications in the interview is language: “structure” here doesn’t mean 3D protein folding. Alex notes that folding becomes relevant for large biologics like interferon, filgrastim, or erythropoietin, but for GLP-class peptides, they’re focused on identity, sequence integrity, and detectable chemical modification.We also talked about thresholds and risk messaging. Uzorak presents specific warning triggers, and Alex described red-level findings as potentially more serious, while also acknowledging that analytical flags are not the same thing as clinical diagnosis. They are not ISO/IEC 17025 accredited yet, but say they follow many of the principles where applicable. Sterility, endotoxin, and heavy metals aren’t included by default currently, though an ICH Q3D-aligned heavy metals panel is planned.Bottom line: this interview focuses on analytical substance, not surface - level claims. It’s about whether grey market testing evolves beyond a reassuring purity percentage into a more complete picture , what’s in the peak, what’s outside it, what’s degraded, and what the limits of testing still are.www.uzorak.com

In this deep dive, we break down drop-shipping in grey peptide markets and why it’s not “just logistics.” In this world, logistics determines custody, accountability, and verification. A polished storefront that accepts PayPal or credit cards may actually be acting as a broker: taking fiat payments, converting to crypto, and routing orders to an upstream supplier the buyer never sees.We also unpack how group buys can function as drop-shipping infrastructure, including direct ship models where organizers never physically handle inventory, and “reverse drop-ship” setups where resellers route customer orders through a group buy to avoid holding stock.Then we connect the structure to the biggest practical failure point: COAs. In layered supply chains, COAs can become representative rather than batch specific, outdated, or disconnected from what a customer actually receives, especially when vials lack unique identifiers.The key mindset shift: stop asking “is this vendor legit?” and start asking “who controls the batch?” Because in a drop-ship model, supply can change overnight, and buyers are often the last to know.Bottom line: drop-shipping isn’t automatically evil. The risk comes from opaque structure, where trust is built on interface and reassurance rather than traceability.

If you’ve ever opened a COA, seen “99% purity,” and felt instant relief… this one’s for you. Because that number is usually HPLC-UV purity, and UV purity isn’t a statement about the whole vial, or even a guarantee of molecular identity. It’s a statement about what the detector can see under a specific method, and how the lab calculates the percentage.In regulated pharma, that UV number sits inside a full GMP quality system, validated processes, controlled inputs, stability programs, and strict release limits. In the grey market, you don’t have that surrounding framework. So the exact same “99%” can be far less reassuring.We break down what UV purity actually measures, why it can miss co-eluting variants and non-UV-friendly contaminants, and why “high purity” doesn’t automatically equal “high net peptide content” once salts, water, and unexpected add-ins enter the picture. We also touch on why some risks, like heavy metals, sterility, and endotoxin, require completely different tests.Bottom line: HPLC-UV isn’t useless. But in the grey market, UV alone can’t carry the meaning people want it to carry.

Same Script, New NameJust when the Bella story looked finished, the pattern resurfaced, under a new name.In Episode 5, the script repeats. A new vendor appears. A polished pitch. A confident backstory. Claims of factory access, quality control, and “no pressure.” The language feels familiar. The structure feels familiar. And then the price list lands, almost identical in layout, formatting, and product order to the ones we’ve already seen.Although the branding is cleaner., the spelling errors are still there. The presentation is sharper. But the workflow hasn’t changed.‎When questioned, the urgency increases. Off platform contact details appear early. Reassurance replaces proof. Pressure stays polite but persistent. The credibility build follows the same ladder: documentation, testimonials, confidence, deflection.‎And when scrutiny grows, so does the performance.‎Episode 5 explores what happens when a scam doesn’t collapse, it evolves. New name. New profile picture. Same funnel.

Undercover at CheckoutThis episode follows an undercover buyer taking Bella to the point that matters: payment.The pattern stays consistent: hook with cheap shipping + fast delivery, deflect COA questions, then pivot the conversation off Discord and into WhatsApp when risk questions appear.At checkout, the “payment ladder” shows up: push crypto first, fall back to PayPal Friends & Family, then rotate to new PayPal accounts (“cashier,” “sister”) when the buyer hesitates. Under pressure, Bella leans on the Zen COAs again, not as proof, but as a reassurance patch, until scrutiny leads to blocking.The typo might change. The workflow doesn’t.

Touchdowns and Testimonials, when the threads convergedThe morning after the Bella interview, Plotting Profits reappears with the same sales loop behaviour: a casual re entry (“hello”), a guilt nudge (“you didn’t get back to me”), then the hook (“prices went down recently”) followed by the familiar move: get the buyer off platform and keep the catalogue moving.That trail leads straight into Alisa’s Discord, branded as “science-based discussion,” but structured as the opposite: broadcast only, read only, no real community conversation. The “discussion” is a controlled feed, dominated by product posts, packaging shots, and carefully placed content meant to look like legitimacy.Then come the touchdowns and testimonials, the emotional, over the top praise (“God sent… only person who stood by me…”) that reads less like normal customer feedback and more like manufactured trust. Alisa replies warmly, then drops the sales line in the same breath: “Still taking orders family.” Gratitude → bonding → transaction.And then the paperwork returns.When you ask about payment and shipping, the setup feels familiar. When you ask about documentation, Zen appears again, the same name that keeps resurfacing across sellers. Explanations shift depending on pressure, but the pattern stays consistent: keep the paperwork sounding official without locking down who it actually belongs to.Episode 3 is where the series title earns its keep: the story isn’t held together by one lie. It’s held together by repetition, the same scripts, the same credibility props, the same “proof,” reused under different faces.

The Interview ; Building BellaThis episode captured the moment Bella stopped being “a vendor” and became a constructed character. In a polished interview for K-Hole, she built credibility layer by layer: a confident backstory, fluent English, personal details, and a professional sounding supply chain. She presented herself as organised and trustworthy while repeatedly anchoring her legitimacy to the Zen name on her COAS.The interview wasn’t just information, it was a credibility token. As the community began cross-checking her claims, the gaps widened: Zen linked documentation, shifting explanations, and rising tension inside the server. Then the pattern surfaced in full: defensive moderation, manufactured praise, and access control. When scrutiny increased, the performance ended the way these funnels often do, messages disappeared, channels tightened, and people were blocked.Episode 2 showed how trust was manufactured in the grey market: not through proof, but through presentation, until the paperwork collapsed the story.

Hello, we are Grey Market VendorsA stranger slides into a Tik Tok inbox with three lines that sound casual but aren’t: “hello,” “we are grey market vendors,” and “are you interested in peptides?” No company. No website. No proof. Just a label used as a shortcut to legitimacy.The conversation quickly shifts to Discord, the real funnel. A profile is shared as “proof,” and a catalogue appears almost immediately. The rhythm is familiar: keep momentum moving, keep questions shallow, keep the buyer engaged.Then the link leads somewhere specific: an invite to Alisa’s server. Not a neutral community, a node in the same orbit that will later connect to Bella. And when the Discord profile is checked, the “vendor” isn’t floating alone. Mutual servers show a network already in place.Episode 1 is the setup: platform hopping as strategy, “community” as a target list, and the first breadcrumb that this wasn’t random outreach, it was infrastructure.

Scam #2 follows the upgraded “agency” version of the Olivia playbook: not just delay tactics, but a full fake logistics world designed to keep victims paying. After the initial purchase is pushed onto irreversible rails, a new “carrier” appears, Global Package Logistics , complete with a tracking portal that looks official until you read it closely. The tracking logic breaks reality (delivery before pickup), fields shift between refreshes, and “Payment Mode: Bitcoin” shows up where no real carrier would ever put it.Then comes the second bite: an email demanding a $155 “refundable insurance fee” to release the parcel, payable via crypto-style methods. Doubt is met with reassurance, not proof, “nothing is weird,” “everyone pays,” “it’ll be refunded with delivery” and the scam tightens further when the seller offers to act as a middleman for the fee.This episode is a walkthrough of how Scam #1 evolves into Scam #2: tracking as theatre, paperwork as pressure, and “refundable” as the word that usually means pay again.

Scam #1: “Tracking Soon” follows a Tik Tok to Telegram peptide supplier funnel that looks like a business right up until it doesn’t. It begins with an instant Excel price list, minimal answers to basic product and testing questions, and a blurry “COA” screenshot used as a trust prop. Once an order is placed, the seller moves fast: collects full delivery details, offers “free vials” to lower hesitation, then insists on PayPal Friends & Family only and asks for manual screenshot proof to “verify” payment.After money is sent, the scam shifts into its core mechanic: the tracking treadmill — tomorrow… can’t register today… lots of shipments… within two hours… thirty minutes… driving home. Eventually a tracking number appears, but it’s routed through an unfamiliar third-party site rather than a real carrier. The final turn is the setup for the second payment attempt, delivered as a casual question: “Did you hear from the agency?”I now have a substack you can subscribe to https://krysia0430.substack.com/p/k-hole-origins-my-road-to-grey?r=6kj0m4

The refund was promised. Then the chat “disappeared.”In this episode of China Peps Exposed, we track the AVA LSPL R20 saga from the first failed test result to weeks of silence, repeated wallet-address requests, shifting refund rules, and mounting reports of underfilled and cloudy vials. A case study in how “we will refund” can turn into a months-long loop of delays, denials, and reputation management, with receipts.I also now have a substack https://substack.com/@krysia0430?r=6kj0m4&utm_medium=ios&utm_source=profile&shareImageVariant=image

Inside the Peptide Underground: A Month-By-Month Saga (PAE) is a narrative documentary series set inside PAE, a group buy Discord server where members pool money for bulk orders of research peptides, track testing results, and navigate constant platform risk.Across Season 1 (Sep 2024–Apr 2025), the community rebuilds after a shutdown, then spirals into paranoia, loyalty purges, and a full-blown feud with rival platform Pepchat. What starts as “safety” messaging becomes control, dissent gets treated like sabotage, and the server fractures into die-hards, quiet skeptics, and people waiting for their orders to land before they leave.Not medical advice. Just the anatomy of an online community under pressure , rebuilding, tightening, rupturing.if you are interested in joining my K hole server and the community, the invite link is belowhttps://discord.gg/w5ZnyBfZ8a

Season 5: Aftermath focuses on what happened in the community chat after Muya vanished, when there was no vendor left to question and the room had to piece together reality on its own. The discussion quickly turns to “who verified her?” and PepChat becomes a central point of confusion, with some members assuming that finding her on PepChat meant she’d been vetted.‎Season 5 makes the key clarification explicit: Muya was not vetted or verified by PepChat. After Christmas, PepChat admins confirmed she had never contacted them, meaning her presence there was simply that, presence, not approval. The season shows how this assumption created a false sense of safety and shifted blame toward platforms and interviewers before the facts were known.‎The season ends with the practical outcome the community chose: interviews will continue, but each one will now include a clear disclaimer that the vendor has not been verified and members must do their own risk assessment, so “being found” or “being featured” can’t be mistaken for being vetted.

Season 4: The Vanish is the moment the story stops being narrative and becomes absence. With tracking expected, the community moves into “routine” mode, until links fail, platforms go dark, and attempts to contact the vendor start hitting dead ends. At first, people assume glitches or holiday delays, but the silence becomes too complete to explain away: Discord gone, Telegram gone, PepChat unreachable.‎As the channels disappear, the conversation shifts from patience to damage control, who ordered, who can still reach them, and how much exposure there is. There’s no final message, no explanation, no attempt to manage the fallout, just a clean removal from existence. Season 4 ends with the unmistakable conclusion that the vendor hasn’t “gone quiet”… they’ve chosen to vanish, leaving the community to face the aftermath alone.

Season 3: The Boss follows the credibility reset attempt after the paperwork damage. Instead of more documents, the solution becomes a voice: a "boss interview” released on Christmas Day, designed to calm the room and put a human figure in charge of the narrative.‎The season centers on how authority is created through tone, access, and emotional storytelling. The interview leans into origin, struggle, and values, shifting attention away from verification and toward character. For many listeners, the reset works: tension drops, empathy replaces suspicion, and momentum returns. But under the reassurance, quiet doubts linger, because the authority being presented feels mediated, curated, and impossible to independently confirm.‎Season 3 ends with the reset seemingly holding. The story is back on track, expectations are set, and the next phase is no longer emotional. It’s practical, where reassurance will be tested by reality.

Season 2: The Paper Cracks begins when the conversation shifts from vibes to verification. COAs enter the picture and community members start comparing details, asking calm but persistent questions about whether the documents match the claims being made.‎As scrutiny increases, the explanation keeps changing, first framed as normal supplier overlap, then as internal miscommunication, and eventually pushed into “PR” territory: the idea that credibility was being presented rather than proven. The atmosphere tightens, moderation becomes more controlling, and questioning gets reframed as “defamation,” turning routine due diligence into a conflict about narrative control.‎Season 2 ends on Christmas Day with a statement that confirms the core issue: the paperwork isn’t what it was presented as. Trust doesn’t collapse yet, but it stops being automatic. The story can’t be repaired with more documents, so the next move is announced: a credibility reset through a new voice, the "boss.”

Season 1: The Build follows how a new vendor becomes “known” in a tense December grey-market climate, before anyone has hard proof either way.‎A polished interview goes live three days before Christmas, and the timing matters: people are tired, supply feels uncertain, and the community is hungry for new options. The season shows how legitimacy is quietly constructed through tone, visibility, and familiarity, how an interview doesn’t verify anything, but can make a name feel real, present, and therefore “safe enough to consider.”‎Season 1 ends at the moment the credibility build is complete: the vendor isn’t a stranger anymore, the community is circling, and the next phase is about to begin, when narrative gives way to paperwork and scrutiny.

In the aftermath of Val’s cupcake scam and Rae’s liquids spin-off, the Discord server settles into audit mode rather than rage. Nancy steps in as the de-facto administrator of the mess: she confirms with Yoyo that roughly $7.5k in BTC really was received, chases down the final $473 overpayment, and publicly posts a breakdown of how that leftover money will be split between affected members.‎But even with Yoyo’s ledger squared, one number never fully materialises: how much money Rae actually took in from the group. The community can see what hit the vendor; they still don’t know the true intake versus what was ever ordered. That gap becomes part of the “emotional loss” column, right next to missing liquids, downgraded doses, and weeks of seizure and C&D stories that were never real.‎Members document everything: labels that don’t match Yoyo’s products, half-dose kits, non-existent return addresses, and shipping labels that look like they were generated to avoid showing Rae’s real details. They talk through what could be reported to banks, payment platforms or law enforcement, sticking to legal options only, while also acknowledging the emotional toll and the limits of how far they’re willing to chase a few hundred dollars each.In the end, the group chooses closure over crusade:• Everyone eligible gets a small pro-rated refund from the recovered funds.• People move their business to more transparent vendors.• Val disappears, Rae stays mostly silent, and trust shifts permanently away from personality-driven group buys.‎The final note isn’t “we got justice” so much as “we got wiser”:cupcakes, liquids, C&Ds and Coinbase hashes all collapse into one core lesson,in grey-market peptides, screenshots are cheap, ledgers matter, and trust is now something you earn in public, not something you ask for in DMs.

The investigation hits its most uncomfortable checkpoint: everyone finally accepts that no peptide liquids were ever ordered for Rae’s GB Yoyo’s side is clear every invoice, tally and chat log shows only peptide kits, no liquid aminos, no seized box, no reship in progress. The "California seizure” has already been dismantled in Episode 3; now we see the practical fallout of that lie.‎Meanwhile, buyers start comparing what did arrive. Some people are still missing entire liquid orders. Others have partial peptide kits, odd substitutions, or nothing at all. In the background, Rae herself admits she has extra peptide kits sitting in her dining room. not labelled as replacements, not clearly assigned to anyone. The picture that emerges isn’t a clean scam with tidy numbers; it’s worse: a chaotic GB where people paid for one basket of products (peps + liquids), and Rae only ever ordered half the basket.‎Episode 6 closes on the unresolved part: refunds and accountability. A few buyers claw money back via banks and apps; many more are stuck in limbo, blocked, ignored, or told to “be patient” months after the fact. The ledger might vindicate Rae on the "did she send BTC to Yoyo?” question, but when it comes to the missing liquids, she’s out of excuses and the community is out of trust.

In this episode the investigation moves off Coinbase and straight into Rae’s Jotform account. Listeners follow Krysia as she watches Rae’s own screen-recording: Jotform dashboards, submission lists, and one carefully chosen example, JA's order.‎JA later confirms her $752 order is correct, which means Rae’s "look, Val changed the form!” demo shows something very awkward: the form matches the buyer, not Rae’s sabotage story. The recording proves Val had some access (she "finished the jotform stuff”) but not that she secretly edited anyone’s order behind their back.‎We then zoom in on the now-infamous Fresno invoice: a December 5th Jotform submission for Val herself, going to a Fresno address. That timing matters, it’s weeks after Rae was already telling people liquids were seized and a reship was underway. The so-called “address leak” and dramatic C&D tale are revisited: the only evidence is a salty text from Val’s husband about a “lawsuit,” not an actual gag order.‎By the end of Episode 5, the "Val tampered with my forms and I was legally silenced” defence looks less like a thriller twist and more like another layer of improv on top of a GB that was already off the rails:• Jotform shows real orders, not edits.• The Fresno form shows Val’s own late order, not proof she stole everyone’s liquids.• And Rae is still the only person who ever claimed those liquids existed in the first place.

This episode follows Rae’s "everything went wrong at once" defence. She tells Krysia that while running the GB she was juggling a daughter with a broken ankle, her own illness and a cancer scare, and that in early December she was suddenly hit with a civil suit and cease-and-desist over an "address leak.” Rae claims she paid "damages,” was suspended from her job for three days after the alleged C&D reached her employer, and that these legal threats are why she "couldn’t say names” or fully explain what happened with the order. The episode lays her whole crisis stack out on a timeline, then contrasts it with the chat history, showing that weeks of seizure stories and liquid promises came first, and the lawsuit / C&D narrative only appeared after buyers had already started asking hard questions.

Episode 3 zooms in on Rae’s favourite alibi: “California customs seized our liquids, I paid half for a reship, it’s on the way.”‎We hear her original announcements about “California has struck,” seized boxes and a heroic reship she’s supposedly funding out of pocket. Buyers repeat that story to each other for weeks, reassuring themselves that delays and missing liquids are just bad luck at the border.‎Then the episode follows what happens when multiple people bypass Rae and message Yoyo directly. One by one, Yoyo’s replies land:• No record of a seized GB.• No customs notice.• No liquid aminos order at the time Rae claimed.‎By the end of the episode the audience sees the full contrast on tape: a loud, detailed seizure narrative from Rae on one side, and a flat, consistent “no seizure, no liquids” from the vendor on the other.‎The conclusion is simple and brutal: the legendary customs seizure never happened, and the entire “reship” arc was a cover story, not a shipping problem.

In Episode 2, the drama shifts from vibes to numbers. With customs stories wearing thin and no liquids in sight, the group finally does what every scammer dreads: they open a spreadsheet. Rae responds by dropping a string of Coinbase screenshots, showing eight BTC payments totalling around $7,500 sent to a single address she says belongs to Yoyo.‎At first, Yoyo’s initial invoice only adds up to about $6.8k in product and shipping, and the chat briefly convinces itself there’s a $700“liquids fund” missing in action. But after Krysia and Yoyo cross-check the transaction hashes properly, the vendor admits her first tally was off: once all eight BTC transfers and a late R20 kit are counted, Rae has actually overpaid by about $473, which Yoyo agrees to refund.‎The result is awkward but important: on the narrow question of whether Rae really sent most of the group’s money to the vendor, the ledger backs her up. She didn’t simply sit on a pile of BTC and vanish. But the corrected numbers don’t conjure any liquids into existence, or explain why no separate liquid order was ever placed. Episode 2 ends with the group crossing “she stole all the money” off the corkboard and replacing it with a subtler problem: Rae sent the funds, but her story about what those funds bought and why buyers still have no oils, is still full of holes.

Episode 1 opens in the aftermath of Val’s cupcake GB disaster: missing kits, bad labels and a community promising never to trust a group buy again. Into that gap steps Rae. a familiar name who openly agrees Val scammed people and repeatedly reassures everyone she’s “not like Val.” She announces a new Yoyo group buy that includes both peptides and “research liquids,” promising cheaper shipping, tracking screenshots and photos of boxes. Members who were burned by Val, including some of the loudest critics from the cupcake saga sign up anyway, sending Rae money via Venmo, Cash App and PayPal because, compared to Val’s silence, her constant chatting and promises look like transparency.‎As the episode progresses, peptides begin to arrive but there is an empty space where the liquids should be. Buyers start asking about tracking for oils and shred kits, and Rae responds with a new explanation: California customs has “struck,” the first box of liquids has supposedly been seized, and she claims to have paid half the cost of a reship herself. At the same time, the GB servers disappear, leaving only Rae’s DMs as the point of contact. Episode 1 ends with those unresolved red flags, no visible liquids, nuked servers, and a host who insists she is nothing like Val. setting up Episode 2’s deeper dive into Rae’s payments and the vendor ledger

Season 4 breaks down the anatomy of Val’s operation, not as a chaotic collapse, but as a controlled system designed to operate behind charm, excuses, and disappearing servers.‎We follow how she structured power, directed payments, delayed refunds, and erased evidence, all while staying likable enough to be believed. From pet names in DMs to multi-platform payment deflection, Val didn’t run her group buy like a business. She ran it like a soft trap, built on emotional leverage and complete backend control.‎This season isn’t about what happened.It’s about how she made it happen again and again.‎Because the real power wasn’t in the product.It was in the pattern.

In Season 3 of The Group Buy Girl, the story turns outward, to the community that was left behind.‎After Val’s silence, shifting stories, and the abrupt shutdown of her server, buyers begin to connect the dots. This isn’t just a delay. It’s a pattern. It’s a problem. And now, it’s a movement.‎The Victims Organise follows how ordinary people, once silent customers, begin to speak up, compare notes, and warn others. Discord DMs turn into group chats. Screenshots become evidence. Refund spreadsheets circulate. And a fractured community starts to rebuild itself, piece by piece, without Val.‎We track the emergence of grassroots accountability: victims documenting timelines, sharing receipts, and pressing for answers. Some manage to get partial refunds. Others are left ghosted. But together, they shape a narrative that Val can no longer control.

In Season 2, the spotlight shifts from Val… to the two women who stood behind her.‎Rae, who helped design the server, built the brand, and organized Val’s operation from the ground up. without ever touching the money.And Steph, a trusted voice in the community, who stepped in to help while also placing an order of her own.‎They weren’t in charge.They weren’t responsible.But when Val disappeared, they were the ones still visible.‎This season explores the emotional and social fallout for two women caught in the middle of someone else’s collapse.They absorbed the blame, the harassment, the unanswered questions. And they did it all without the power to fix what had already broken.‎Season 2 is a story about unpaid labour, misplaced trust, and the toll of being almost in charge of something you never controlled.

This season tells the story of Val B, a trusted figure in the online DIY peptide and beauty community and how her growing group buy operation unravelled into silence, confusion, and financial loss. Through Discord logs, payment receipts, and the voices of collaborators and victims, Season 1 explores how trust is built online, and how easily it can be used against you.From her breakout success in a shared server, to a curated brand and eventual disappearance, Val’s journey is told in full, by the people who helped her rise, and the ones left behind when she vanished.

AFTERMATH; Fallout from the Seralyte CaseIn this short follow up season, the focus moves from the Seralyte allegations themselves to what happened after Nova published her investigation. Once she posts that the hot-pack and fake-postage accusations against Seralyte are unproven on the evidence she’s seen, the LabTrack Discord is nuked and the conversation shifts to the LabTrack Telegram backchannel. There, Vern, Guy and others vent about “dangerous messages” calming people down and insist that “trustworthy people” have seen proof – proof that is still never shown to Nova.Guy then posts a long message clarifying that the Danger label on Seralyte was actually his personal decision, made quickly and emotionally, not the result of a unanimous mod vote, even though other mods share his concerns. When LabTrack eventually rebuilds its Discord, Nova notices she’s simply not invited back, despite having funded and helped lead tests. Later, a friendlier mod (Owl) sends her old test results and explains that the new server is meant to be smaller and more “vanilla,” with less overlap with visible investigators. When Nova shares her Seralyte timeline and screenshots, Owl doesn’t argue with the details – he just agrees that Guy clearly took the whole situation personally.By the end of Aftermath, Seralyte remains treated as high risk inside LabTrack, Nova remains outside the lab she once contributed to, and the “proof” she was told to trust has still never been fully shown to her. The real story of this season isn’t whether Seralyte is good or bad – it’s how asking to see the receipts changed who was trusted, who was welcome, and who ended up on the other side of the door

Season 3, **"Vetted Until You Speak,”** covers what happens when EPU takes the HYB warning into STG.EPU posts the full HYB chat and 0% COA in STG so people know a 36 IU vial tested at zero. The post is deleted, both EPU admins are banned, and a mod tells Kermit he broke **"no group buy / no HGH”** rules and that HYB’s buyers are **"his customers”** he should refund. Shortly after, STG quietly removes European Peptide Union from its vetted EU groups list.Inside EPU, they pin a statement arguing that removing them doesn’t protect anyone; it punishes one of the only groups actually acting in members’ best interests. Season 3 shows how a vetted group becomes “a vendor” and gets de-vetted the moment it speaks too loudly about a vendor failure.

Season 2, “Damage Control,” covers everything that happened after the 36 IU vial tested at 0%.HYB’s first response is to complain about “propaganda,” demand proof from Georg, and only then honour their promise to refund him and cover the Janoshik fee. Publicly they blame a mysteriously “arrested factory,” announce that only two batches were affected, and close their chat channels “to protect customers from scammers,” while privately admitting they never tracked batches properly and were working off “estimated” purities.The season ends with HYB pushing a neat PR story about raids and refunds, and EPU quietly preparing to do the one thing HYB clearly doesn’t want: warn the wider community.

Season 1: The Group BuySeason 1, “The Group Buy,” tells the story of how a vetted European community (EPU) organised an HGH group buy with HYB/ Yura that was supposed to be safe and routine.We see:EPU’s background as a testing-first, non-vendor group.HYB offering untested HGH 24 IU and 36 IU, promising to pay for Janoshik testing and refunds if anything is wrong.Early red flags: TR20 COA that doesn’t match the caps, no batch numbers, a “sample batch” sold out and replaced with a new batch of “estimated 97% purity.”The group buy landing with five different cap colours (multiple untracked batches in one order).A 24 IU purple cap testing fine at Janoshik, while other caps remain untested.Member Georg sending a 36 IU red-cap vial to Janoshik and receiving a COA showing 0% HGH.Season 1 ends with that result and Georg’s message to HYB:“Hello Yura. I need an explanation. No HGH found in the sample.”

Season 3 – Danger Tag & the Seralyte Labs Hot-Pack CaseA LabTrack member we call Rook claims that Seralyte Labs sent him a “hot pack” after an argument. Inside LabTrack, people he knows vouch for him; mods say they’ve seen enough in private, and Seralyte is quickly moved to the Vendor Beware path. But when Nova asks for details so she can warn her own servers, Rook refuses to show full evidence, the timeline wobbles, and every request for receipts hits a wall.Nova goes digging. A second supposed victim, Vern, insists postal workers confirmed fake postage but also won’t share documentation. Another mod, Kit, talks directly with Seralyte’s rep and decides the hot-pack story doesn’t match what she’s shown. Stuck between “believe trusted members” and “show your work,” Nova chooses the only position she can defend publicly: she posts an investigation saying the hot-pack and fake-postage allegations, as presented to her, are unproven.LabTrack keeps Seralyte on a danger trajectory. Nova’s servers now host a post that partially clears those specific accusations. When Guy reads it, he doesn’t hear “this part of the story doesn’t hold up”, he hears Nova running PR for a vendor he already considers dangerous. His DMs come in hard and relentless, accusing her of siding with Seralyte and failing as an investigator. She experiences those messages as intimidating and intrusive; he believes he’s protecting the community.By the end of Season 3, the Danger tag on Seralyte is permanent, Rook and Vern still refuse to go public with receipts, and whatever fragile trust existed between Nova and Guy has blown apart. LabTrack now trusts its insiders; Nova trusts only what she can actually show. The series title finally turns inward: in this season, the biggest trust issues are between each other.